Zacks.com on MSN
Meta Platforms Earnings: Watch These Key Metrics
Beloved Mag 7 member Meta Platforms is on the reporting docket this week. These are the key metrics worth paying attention to ...
PYPL's Q3 results hinge on steady TPV gains, new AI and commerce tools, and key deals driving modest growth momentum.
Repligen expects full-year earnings in the range of $1.65 to $1.68 per share, with revenue in the range of $729 million to $737 million. This story was generated by Automated Insights ( ...
The largest U.S. health insurer posted revenue of $113.16 billion in the period, which did not meet Street forecasts. Eight analysts surveyed by Zacks expected $113.36 billion. UnitedHealth expects ...
NEW YORK (AP) — NEW YORK (AP) — Travelzoo (TZOO) on Tuesday reported third-quarter profit of $151,000. On a per-share basis, the New York-based company said it had net income of 1 cent. The results ...
Wayfair Inc. (W) on Tuesday reported a loss of $99 million in its third quarter. On a per-share basis, the Boston-based company said it had a loss of 76 cents.
Zacks Investment Research on MSN
Should Lam Research Stock Be in Your Portfolio Post Solid Q1 Earnings?
Lam Research Corporation LRCX recently posted robust first-quarter fiscal 2026 results, helping its shares rise 11% since the ...
Zacks Investment Research on MSN
Lam Research Corporation (LRCX) Hits Fresh High: Is There Still Room to Run?
Shares have been marching higher, with the stock up 19.7% over the past month. The stock hit a new 52-week high of $158.25 in the previous session. Lam Research has gained 117.2% since the start of ...
In the latest close session, NIO Inc. (NIO) was up +2.03% at $7.04. The stock's change was more than the S&P 500's daily gain of 1.23%. Elsewhere, the Dow saw an upswing of 0.72%, while the tech-heavy ...
A lot of money has been spent on setting up artificial intelligence (AI) infrastructure in the past three years, and it looks ...
In the randomized, double-blind, pediatric and adolescent, placebo-controlled study, CTx-1301 delivered rapid onset of effect and sustained efficacy through the evening hours. Safety and tolerability ...
On a per-share basis, the Charlotte, North Carolina-based company said it had net income of $2.63. The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results